Neoplasm
Clinical trials for Neoplasm explained in plain language.
Never miss a new study
Get alerted when new Neoplasm trials appear
Sign up with your email to follow new studies for Neoplasm, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental cancer drug trial halted early
Disease control Stopped earlyThis study tested a new drug called SAR444200, alone or with other cancer treatments, in 33 adults with advanced solid tumors that had spread and were not responding to standard therapy. The main goals were to check safety and find the right dose. The trial was terminated early, …
Matched conditions: NEOPLASM
Phase 1/2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Experimental HER2 drug trial halted early – what it means
Disease control Stopped earlyThis early-stage trial tested an experimental drug called SAR443216 in 44 adults with advanced HER2-expressing solid tumors (such as breast, lung, or gastric cancer) that had come back or stopped responding to standard treatments. The study aimed to find a safe dose and check for…
Matched conditions: NEOPLASM
Phase 1 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 26, 2026 17:22 UTC
-
Tracing a cancer Drug's path through the body
Knowledge-focused Stopped earlyThis early-phase study by AstraZeneca examines how the experimental drug ceralasertib is absorbed, distributed, and eliminated in people with advanced solid tumors. Participants receive the drug orally and a tiny radiolabeled intravenous dose to track its journey. Researchers mea…
Matched conditions: NEOPLASM
Phase 1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC